Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Xenetic biosciences, inc. symbols : BAX save search
Xenetic Biosciences Announces Ticker Symbol Change to XBIO
Published: 2014-02-14 (Crawled : 07:00) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
bioscience
Xenetic Biosciences Announces Opening of Corporate Headquarters and R&D Facility in Lexington, MA
Published: 2014-03-04 (Crawled : 07:00) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
bioscience
Xenetic Biosciences Appoints Darlene Deptula-Hicks to Board of Directors
Published: 2014-04-04 (Crawled : 07:00) - globenewswire.com
ICAD | $1.56 28K
|
Technology Services
| Email alert
Add to watchlist
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
ABMD | $381.02 0.06% 0.07%
|
Health Technology
| Email alert
Add to watchlist
bioscience
Xenetic Biosciences Announces Positive Phase 1 Clinical Data for PulmoXen(TM) for Treatment of Cystic Fibrosis
Published: 2014-04-07 (Crawled : 07:00) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
treatment fibrosis phase 1 positive phase 3 phase 2 cystic fibrosis
Xenetic Biosciences Announces Positive Phase 1 Clinical Results for PSA-Oxyntomodulin for the Treatment of Type II Diabetes and Obesity
Published: 2014-05-12 (Crawled : 00:20) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
diabetes treatment obesity phase 1 positive results phase 3 phase 2
Xenetic Biosciences Announces First Quarter 2014 Financial Results and Business Update
Published: 2014-05-21 (Crawled : 00:20) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
financial results results bioscience
Xenetic Biosciences to Present at the Third Annual Marcum MicroCap Conference
Published: 2014-05-29 (Crawled : 00:20) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
conference bioscience
Xenetic Biosciences Strengthens Technology Patent Portfolio
Published: 2014-06-09 (Crawled : 00:20) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
patent technology bioscience
Xenetic Biosciences Announces Dosing of First Patient on Dialysis in Phase 2a Clinical Study of ErepoXen(R)
Published: 2014-06-11 (Crawled : 00:20) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
phase 2 phase 2b dialysis
Xenetic Biosciences Announces Ongoing Safety Data From Phase 2 Trial of ErepoXen(R)
Published: 2014-06-30 (Crawled : 00:20) - globenewswire.com
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
phase 2 ongoing trial bioscience
Xenetic Biosciences Announces Board Change
Published: 2015-04-21 (Crawled : 13:59) - globenewswire.com
XBIO | $3.78 640
|
Health Technology
| Email alert
Add to watchlist
BAX | $40.005 -2.26% 670K
|
Health Technology
| Email alert
Add to watchlist
change
Gainers vs Losers
| 46% | 54% |
Top 10 Gainers
SGBX | $0.26 80.43% 54M
|
Producer Manufacturing
LICN | $1.0 78.57% 3.3M
|
CSSE 4 | $0.2656 74.39% 9.7M
|
Consumer Services
BRFH 4 | $1.89 71.82% 32M
|
Manufacturing
ACON | $0.49 70.14% 24M
|
n/a
BOF | $1.95 66.67% 920K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.22 61.0% 720K
|
Technology Services
PCSA | $2.28 40.74% 37M
|
Producer Manufacturing
EVA | $0.626 39.14% 2.3M
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.